Related references
Note: Only part of the references are listed.Renin Inhibitors and Cardiovascular and Renal Protection: An Endless Quest?
Michel Azizi et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
New Renin Inhibitor VTP-27999 Alters Renin Immunoreactivity and Does Not Unfold Prorenin
Manne Krop et al.
HYPERTENSION (2013)
Aliskiren accumulation in the kidney: no major role for binding to renin or prorenin
Sascha Lange et al.
JOURNAL OF HYPERTENSION (2013)
Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility
Lanqi Jia et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement
Duncan J. Campbell et al.
CLINICAL CHEMISTRY (2009)
Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans
Naomi D. L. Fisher et al.
CIRCULATION (2008)
Clinical pharmacokinetics and pharmacodynamics of Aliskiren
Sujata Vaidyanathan et al.
CLINICAL PHARMACOKINETICS (2008)
Circulating versus tissue renin-angiotensin system: On the origin of (pro)renin
Manne Krop et al.
CURRENT HYPERTENSION REPORTS (2008)
Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats
David L. Feldman et al.
HYPERTENSION (2008)
Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors
Maarten A. D. H. Schalekamp et al.
JOURNAL OF HYPERTENSION (2008)
Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans
M Azizi et al.
HYPERTENSION (2004)
Share Paper
